Green Leaf Medical AB (Stockholm) has patented a production process for spinach-derived thylakoids, which the company claims can promote appetite suppression.
Green Leaf Medical AB (Stockholm) has patented a production process for spinach-derived thylakoids, which the company claims can promote appetite suppression.
Thylakoids are membrane-bound compartments found inside the chloroplasts of plant cells. According to Green Leaf, in vitro and in vivo studies indicate that these substances can prevent fat and carbohydrate assimilation and promote appetite reduction for at least six hours.
While the company is planning long-term studies for 2011 and 2012 and preparing for US and EU regulatory processes, Green Leaf says that it will have a market-ready product by 2012. The company continues to explore its ingredient for use in dietary supplements, functional foods, and beverages.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.